Predictive Oncology ends merger talks with Renovaro; LOI expired March 31, 2025

Axe Compute Inc.

POAI discontinued discussions with Renovaro (RENB) regarding proposed merger; LOI expired March 31, 2025.
POAI denies entering into a binding merger agreement; contradicts RENB's April 4, 2025 press release.
Extension agreement extended LOI term to March 31, 2025; POAI has no further obligations to RENB.
POAI reaffirms commitment to AI-driven drug discovery and drug development.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.